(Q45507304)

14 December 2017

Virus-like particle expression and assembly in plants: hepatitis B and Norwalk viruses (English)

1 reference

14 December 2017

1 reference

1 reference

3

1 reference

14 December 2017

7

Hugh S Mason

1 reference

14 December 2017

Zhong Huang

1

1 reference

14 December 2017

Galina Elkin

2

1 reference

14 December 2017

Norene Beuhner

4

1 reference

14 December 2017

Charles J Arntzen

5

1 reference

14 December 2017

Yasmin Thanavala

6

1 reference

14 December 2017

language of work or name

English

0 references

publication date

1 March 2005

1 reference

14 December 2017

1 reference

14 December 2017

23

1 reference

14 December 2017

15

1 reference

14 December 2017

1851-1858

1 reference

Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers

14 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.017

Human immune responses to a novel norwalk virus vaccine delivered in transgenic potatoes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.017

Edible plant vaccines: applications for prophylactic and therapeutic molecular medicine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.017

Oral immunization with hepatitis B surface antigen expressed in transgenic plants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.017

Expression of hepatitis B surface antigen in transgenic plants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.017

Structural characterization of plant-derived hepatitis B surface antigen employed in oral immunization studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.017

Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.017

A plant signal peptide-hepatitis B surface antigen fusion protein with enhanced stability and immunogenicity expressed in plant cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.017

Oral immunization with a recombinant bacterial antigen produced in transgenic plants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.017

Conformational analysis of hepatitis B surface antigen fusions in an Agrobacterium-mediated transient expression system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.017

New plant binary vectors with selectable markers located proximal to the left T-DNA border

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.017

Expression of the B subunit of Escherichia coli heat-labile enterotoxin as a fusion protein in transgenic tomato.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.017

Process options in hepatitis B surface antigen extraction from transgenic potato

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.017

Synthesis and assembly of hepatitis B virus surface antigen particles in yeast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.017

A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.017

Comparative safety and immunogenicity of yeast recombinant hepatitis B vaccines containing S and pre-S2 + S antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.017

Safety and efficacy of a recombinant yeast-derived pre-S2 + S-containing hepatitis B vaccine (TGP-943): phase 1, 2 and 3 clinical testing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.017

Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.017

The structure of hepatitis B envelope and molecular variants of hepatitis B virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.017

Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.017

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2004.11.017

1 reference

14 December 2017

1 reference